Cerium oxide nanoparticles, nanoceria, are inorganic antioxidants that have catalytic activities which mimic those of the neuroprotective enzymes superoxide dismutase and catalase. We have previously shown that nanoceria preserve retinal morphology and prevent loss of retinal function in a rat light damage model. In this study, the homozygous tubby mutant mouse, which exhibits inherited early progressive cochlear and retinal degeneration, was used as a model to test the ability of nanoceria to slow the progression of retinal degeneration. Tubby mice were injected systemically, intracardially, with 20 μl of 1 mM nanoceria in saline, at postnatal day 10 and subsequently at P20 and P30 whereas saline injected and uninjected wild type (or heterozygous tubby) served as injected and uninjected controls, respectively. Assays for retinal function, morphology and signaling pathway gene expression were performed on P34 mice. Our data demonstrate that nanoceria protect the retina by decreasing Reactive Oxygen Species (ROS), up-regulating the expression of neuroprotection-associated genes; down-regulating apoptosis signaling pathways and/or up-regulating survival signaling pathways to slow photoreceptor degeneration. These data suggest that nanoceria have significant potential as global agents for therapeutic treatment of inherited retinal degeneration and most types of ocular diseases.
Introduction
Inherited retinal degeneration results in the apoptotic death of photoreceptors, and sometimes the retinal pigment epithelial cells (Chang et al., 1993; Portera-Cailliau et al., 1994) , through caspasedependent and -independent apoptotic pathways (Wenzel et al., 2005) . It had been hypothesized, and experimentally demonstrated, that neurodegenerative ocular diseases can be directly linked with excessive oxidative stress (Dorrell et al., 2009; Komeima et al., 2006; Sanz et al., 2007) due to a rise in the level of reactive oxygen species (ROS) beyond the capacity of the cells' antioxidant defenses (Andersen, 2004; Cingolani et al., 2006) . Documented data indicate that supplementation with agents such as sulforaphane (SF) (Gao and Talalay, 2004; Kong et al., 2009 Kong et al., , 2007 Tanito et al., 2005) , thioredoxin (Cohen et al., 2009 ) and others (Komeima et al., 2006; Sanz et al., 2007) can eliminate these pathological conditions. Similarly, neurotrophic proteins such as BDNF (brain-derived neurotrophic factor) and PEDF (pigment epithelium-derived factor) can protect against photoreceptor degeneration and preserve the retinal function in some animal models (Klocker et al., 2000; Schuettauf et al., 2004) .
Investigations of cerium oxide nanoparticles (nanoceria) have revealed that their lattice constant increases with decreasing nanoparticle size (Deshpande et al., 2005) . The surface area of nanoceria is dramatically increased in relation to its volume which increases the probability of oxygen exchange and redox reactions. This increase in surface activity has been attributed to an increase in oxygen vacancies in the nanocrystalline lattice (Patil et al., 2006) . We hypothesized that nanoceria, owing to their chemical and physical properties, can protect cells from free-radical-induced damage. This is especially supported by the demonstration that nanoceria have catalytic activities like those of two major anti-oxidative enzymes, super oxide dismutase (Korsvik et al., 2007) and catalase (Pirmohamed et al., 2010; Karakoti et al., 2009) , and act as direct antioxidants and neuroprotective agents to limit the
